期刊文献+
共找到299篇文章
< 1 2 15 >
每页显示 20 50 100
Newly Detected Transmission of bla_(KPC-2) by Outer Membrane Vesicles in Klebsiella Pneumoniae 被引量:1
1
作者 Liu-jun CHEN Xiao-peng JING +6 位作者 Dong-li MENG Ting-ting WU Huan ZHOU Rui-ling SUN Xiao-chun MIN Rong LIU Ji ZENG 《Current Medical Science》 SCIE CAS 2023年第1期80-85,共6页
Objective The prevalence of carbapenem-resistant Klebsiella pneumoniae(CR-KP)is a global public health problem.It is mainly caused by the plasmid-carried carbapenemase gene.Outer membrane vesicles(OMVs)contain toxins ... Objective The prevalence of carbapenem-resistant Klebsiella pneumoniae(CR-KP)is a global public health problem.It is mainly caused by the plasmid-carried carbapenemase gene.Outer membrane vesicles(OMVs)contain toxins and other factors involved in various biological processes,includingβ-lactamase and antibiotic-resistance genes.This study aimed to reveal the transmission mechanism of OMV-mediated drug resistance of Klebsiella(K.)pneumoniae.Methods We selected CR-KP producing K.pneumoniae carbapenemase-2(KPC-2)to study whether they can transfer resistance genes through OMVs.The OMVs of CR-KP were obtained by ultracentrifugation,and incubated with carbapenem-sensitive K.pneumoniae for 4 h.Finally,the carbapenem-sensitive K.pneumoniae was tested for the presence of bla_(KPC-2)resistance gene and its sensitivity to carbapenem antibiotics.Results The existence of OMVs was observed by the electron microscopy.The extracted OMVs had bla_(KPC-2)resistance gene.After incubation with OMVs,bla_(KPC-2)resistance gene was detected in sensitive K.pneumoniae,and it became resistant to imipenem and meropenem.Conclusion This study demonstrated that OMVs isolated from KPC-2-producing CR-KP could deliver bla_(KPC-2)to sensitive K.pneumoniae,allowing the bacteria to produce carbapenemase,which may provide a novel target for innovative therapies in combination with conventional antibiotics for treating carbapenem-resistant Enterobacteriaceae. 展开更多
关键词 bla_(kpc-2) carbapenem-resistant klebsiella pneumoniae carbapenemase outer membrane vesicles simplified carbapenem inactivation method
下载PDF
A Five-year Surveillance of Carbapenemase-producing Klebsiella pneumoniae in a Pediatric Hospital in China Reveals Increased Predominance of NDM-1 被引量:12
2
作者 DONG Fang LU Jie +7 位作者 WANG Yan SHI Jin ZHEN Jing Hui CHU Ping ZHEN Yang HAN Shu Jing GUO Yong Li SONG Wen Qi 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2017年第8期562-569,共8页
Objective To characterize carbapenem (CPM)-non-susceptible Klebsiella pneumoniae (K. pneumoniae) and carbape-nemase produced by these strains isolated from Beijing Children's Hospital based on a five-year surveil... Objective To characterize carbapenem (CPM)-non-susceptible Klebsiella pneumoniae (K. pneumoniae) and carbape-nemase produced by these strains isolated from Beijing Children's Hospital based on a five-year surveillance. Methods The Minimal Inhibition Concentration values for 15 antibiotics were assessed using the Phonixl00 compact system. PCR amplification and DNA sequencing were used to detect genes encoding carbapenemases. WHONET 5.6 was finally used for resistance analysis. Results In total, 179 strains of CPM-non-susceptible K. pneumoniae were isolated from January, 2010 to December, 2014. The rates of non-susceptible to imipenem and meropenem were 95.0% and 95.6%, respectively. In the 179 strains, 95 (53.1%) strains carried the blalMP gene, and IMP-4 and IMP-8 were detected in 92 (96.8%) and 3 (3.2%) IMP-producing isolates, respectively. 65 (36.3%) strains carried the blaNDM_1 gene. 6 (3.4%) strains carried the blaKpc gene, and KPC-2 were detected in 6 KPC-producing isolates. In addition, New Delhi-Metallo-1 (NDM-1) producing isolates increased from 7.1% to 63.0% in five years and IMP-4 producing isolates decreased from 75.0% to 28.3%. Conclusion High frequencies of multiple resistances to antibiotics were observed in the CPM-non-susceptible K. pneumoniae strains isolated from Beijing Children's Hospital. The production of IMP-4 and NDM-1 metallo-13-1actamases appears to be an important mechanism for CPM-non- susceptible in K. pneumoniae. 展开更多
关键词 klebsiella pneumoniae carbapenemaseS Microbial drug resistance
下载PDF
<i>Klebsiella pneumoniae</i>Carbapenamase (KPC) Outbreak in a Multispeciality Cancer Hospital—An Emerging Superbug
3
作者 Sulav Sapkota Shobha K. Ganesan +2 位作者 Mona Priyadarshini Shobha Savitha A. Radheshyam Naik 《Advances in Infectious Diseases》 2019年第3期162-170,共9页
Aim: To identify, analyse and control the outbreak of Carbapenamase producing Klebsiella pneumoniae. Objectives: 1) To detect multidrug resistant K. pneumoniae at the earliest and isolate patients. 2) To find out the ... Aim: To identify, analyse and control the outbreak of Carbapenamase producing Klebsiella pneumoniae. Objectives: 1) To detect multidrug resistant K. pneumoniae at the earliest and isolate patients. 2) To find out the predisposing causes for the occurrence of this outbreak. 3) To break the chain of infection transmission. 4) To reduce the risk of Hospital acquired infections. Methods: This retrospective study along with the surveillance was conducted from January 2017 to March 2017 at HCG multispecialty cancer hospital, Bangalore, India. Results: Total 15 patients were diagnosed with KPC infection during the first month of the study period. Those affected were mostly Male patients (73%), admitted in ICU (73%) for further treatment. In our study, the incidence of KPC infection was mostly found with bloodstream infections (60%), mostly seen in those with central lines (80%) followed by patients on ventilatory support (66%). Before the outbreak of KPC infection, all the patients (100%) had already been treated with higher antibiotics including Carbapenems. In our study, only nine out of fifteen patients (60%) could be salvaged with treatment and were discharged. Conclusions: Hospital Infection Control Committee’s regular screening and the training of healthcare professionals are vital for the control of the outbreak. 展开更多
关键词 Intensive Care Unit (ICU) klebsiella pneumoniae Carbapenamase (kpc) OUTBREAK
下载PDF
产KPC肺炎克雷伯菌感染治疗的研究进展
4
作者 马艳秋 吴振超 +1 位作者 杜毅鹏 沈宁 《中国感染控制杂志》 CAS CSCD 北大核心 2024年第2期250-256,共7页
近年来全国耐碳青霉烯类肺炎克雷伯菌(CRKP)分离率逐年上升,且由于其多重耐药、病死率高的特点,给临床治疗带来了严峻挑战。CRKP耐药最主要机制为产碳青霉烯酶,在CRKP中常见的碳青霉烯酶类型为Ambler A、B、D类,C类少见。碳青霉烯酶中... 近年来全国耐碳青霉烯类肺炎克雷伯菌(CRKP)分离率逐年上升,且由于其多重耐药、病死率高的特点,给临床治疗带来了严峻挑战。CRKP耐药最主要机制为产碳青霉烯酶,在CRKP中常见的碳青霉烯酶类型为Ambler A、B、D类,C类少见。碳青霉烯酶中最常见的是肺炎克雷伯菌碳青霉烯酶(KPC),属于A类。产KPC肺炎克雷伯菌(KPC-KP)在全球范围内广泛扩散,临床有效治疗药物非常有限。本文就KPC-KP感染治疗的研究进展进行总结,以期为临床治疗提供借鉴意义。 展开更多
关键词 肺炎克雷伯菌 碳青霉烯酶 治疗 美罗培南/法硼巴坦 头孢他啶/阿维巴坦
下载PDF
产NDM-1和产KPC-2耐碳青霉烯类肺炎克雷伯菌临床及分子流行病学特征比较
5
作者 殷丽军 卢露 +2 位作者 何磊燕 武娜娜 王传清 《中国感染控制杂志》 CAS CSCD 北大核心 2024年第5期556-562,共7页
目的比较产NDM-1和产KPC-2耐碳青霉烯类肺炎克雷伯菌(CRKP)的临床及分子流行病学特征。方法回顾性分析2017—2020年某儿童医院非重复儿童住院患者临床分离的CRKP,查阅菌株来源患者的病历资料获得患者的基本临床特征。对CRKP进行药敏试... 目的比较产NDM-1和产KPC-2耐碳青霉烯类肺炎克雷伯菌(CRKP)的临床及分子流行病学特征。方法回顾性分析2017—2020年某儿童医院非重复儿童住院患者临床分离的CRKP,查阅菌株来源患者的病历资料获得患者的基本临床特征。对CRKP进行药敏试验及多位点序列分型(MLST)分析,比较产NDM-1和产KPC-2的CRKP临床及分子流行病学特征。结果2017—2020年共收集164株CRKP菌株,其中96株携带bla NDM-1,68株携带bla KPC-2,产NDM-1的CRKP主要分布在新生儿科室,产KPC-2的CRKP以非新生儿科室居多,两组在标本来源、患者年龄、科室分布和预后情况方面比较,差异均有统计学意义(均P<0.05);产NDM-1的CRKP菌株以ST 17型和ST 278型为主,分别为40.63%、18.75%;而产KPC-2的CRKP菌株以ST 11为主,达73.53%。产KPC-2的CRKP分离株对头孢吡肟、氨曲南、亚胺培南、阿米卡星、庆大霉素、呋喃妥因和磷霉素的耐药率均高于产NDM-1的CRKP分离株,差异均有统计学意义(均P<0.05)。结论产NDM-1和产KPC-2的CRKP菌株在临床及分子流行病学方面均存在差异,产KPC-2的CRKP菌株表现出更严重的耐药性,感染KPC-2 CRKP的患者预后较差,应引起临床和感控的重视。 展开更多
关键词 耐碳青霉烯类肺炎克雷伯菌 kpc-2 NDM-1 ST 11 ST 17 CRKP 流行病学特征
下载PDF
建立一种适合本实验室快速检测产KPC酶肺炎克雷伯菌的方法
6
作者 滕元姬 易雪丽 +2 位作者 陈晓颖 罗斌 王春芳 《右江医学》 2024年第8期740-745,共6页
目的运用基质辅助激光解吸电离飞行时间质谱技术(MALDI-TOF MS)检测产肺炎克雷伯菌碳青霉烯酶(KPC)耐碳青霉烯类肺炎克雷伯菌(CRKP),筛选并验证其特征峰,建立一种适用于本实验室快速检测产KPC酶型CRKP的方法。方法收集临床耐碳青霉烯类... 目的运用基质辅助激光解吸电离飞行时间质谱技术(MALDI-TOF MS)检测产肺炎克雷伯菌碳青霉烯酶(KPC)耐碳青霉烯类肺炎克雷伯菌(CRKP),筛选并验证其特征峰,建立一种适用于本实验室快速检测产KPC酶型CRKP的方法。方法收集临床耐碳青霉烯类肺炎克雷伯菌39株,运用PCR方法检测出其中23株产KPC酶,再采用MALDI-TOF MS技术检测KPC酶阳性CRKP菌株,得到质谱图后用Flex Analyst软件分析筛选出其中特征峰,并进行重复性实验和临床验证评估。结果综合筛选出产KPC酶CRKP最佳特征峰为m/z 6432,特征峰验证实验和重复性实验的特异性和敏感性分别为96.67%和100%。临床验证评估特异性和敏感性分别为92.31%和100%。结论利用MALDI-TOF MS技术可检出产KPC酶CRKP的最佳特征峰为m/z 6432,经实验证实该特征峰特异性和敏感性高,可为临床快速诊断和治疗产KPC酶CRKP提供理论基础。 展开更多
关键词 基质辅助激光解吸电离飞行时间质谱技术 特征峰 肺炎克雷伯菌 碳青霉烯酶
下载PDF
ST11肺炎克雷伯菌QL5株携带的质粒pQL5-NDM-KPC的研究
7
作者 马超越 王笑 +2 位作者 刘真真 贾楠 朱元祺 《中国实验诊断学》 2024年第4期401-404,共4页
目的探讨肺炎克雷伯菌QL5株携带编码碳青霉烯酶基因的质粒及其特性。方法基于二代Illumina和三代Nanopore测序技术平台获得菌株的基因组和质粒序列,然后用一系列软件分析菌株的生物学信息。S1核酸酶切脉冲场凝胶电泳、质粒液相接合试验... 目的探讨肺炎克雷伯菌QL5株携带编码碳青霉烯酶基因的质粒及其特性。方法基于二代Illumina和三代Nanopore测序技术平台获得菌株的基因组和质粒序列,然后用一系列软件分析菌株的生物学信息。S1核酸酶切脉冲场凝胶电泳、质粒液相接合试验和稳定性试验检测菌株携带的质粒特性。结果生信分析显示:肺炎克雷伯菌QL5株携带的bla_(NDM-1)和bla_(KPC-2)基因位于同一个IncC/IncFII(PHN7A8)/IncR杂合质粒上(命名为pQL5-NDM-KPC);QL5株携带的pQL5-NDM-KPC可发生bla_(NDM-1)基因所在区域的片段丢失。结论经检索,携带bla_(NDM-1)和bla_(KPC-2)基因位于同一个IncC/IncFII(PHN7A8)/IncR杂合质粒pQL5-NDM-KPC(GenBank序列号:OR253888)上,为国内外首次报道。 展开更多
关键词 肺炎克雷伯菌 blakpc-2 blaNDM-1 质粒
下载PDF
Antimicrobial Resistance Patterns and Molecular Characterization of <i>Klebsiella pneumoniae</i>in Clinical Isolates at Mbarara Regional Referral Hospital 被引量:4
8
作者 Joseph Turugurwa James Mwesigye +3 位作者 Kennedy Kassaza Fredrick Byarugaba Taseera Kabanda Benson Musinguzi 《Advances in Infectious Diseases》 2019年第3期197-225,共29页
Background: Klebsiella pneumoniae is one of the most frequent opportunistic pathogens causing a range of infections and being resistant for beta-lactamases (ESBL) and Carbapenemases. Aim: The aim of the present study ... Background: Klebsiella pneumoniae is one of the most frequent opportunistic pathogens causing a range of infections and being resistant for beta-lactamases (ESBL) and Carbapenemases. Aim: The aim of the present study was to determine the antimicrobial resistance patterns and molecular characterization establishing the phenotypes and genotypes associated with drug resistance, an antibiogram of genotypically positive isolates for resistance of Klebsiella pneumoniae in clinical isolates at MRRH. Materials and Methods: A laboratory-based descriptive cross-sectional study that was conducted from September 2018 to May 2019 at MRRH. Klebsiella pneumoniae was identified by cultural and biochemical methods. Antibiotic sensitivity test was performed by modified Kirby-Bauer disc diffusion technique. ESBL production in Klebsiella pneumoniae was tested by double-disc synergy test, Carbapenemase production by MHT, Boronic Acid or EDTA test using Meropenem phenotypically and both resistance confirmed genotypically by Multiplex PCR. Results: Out of 1055 clinical isolates, 298 (28.2%) were found positive for Klebsiella.spp, 175 isolates were subcultured among which 22 (12.57%) were K. pneumoniae based on API 20E. Overall Sensitivity patterns of these Klebsiella pneumoniae isolates to Ceftriaxone, (Amoxicillin/Clavulanate), Gentamicin, Cefepime, Ciprofloxacin, Cefoxitin, Nitrofurantoin, Cefuroxime, piperacillin/tazobactam, Meropenem, Ceftazidime and cefotaxime were 72.7%, 63.7%, 54.5%, 45.5%, 31.8%, 31.8%, 27.3%, 27.3%, 22.7%, 22.7%, 18.2%, 9.1%, 9.1% respectively. ESBL producing K. pneumoniae was found at 68.18% (15/22) phenotypically. Genotypically;the ESBL genes were blaCTX-M (100%), blaSHV (80%) and blaTEM (100;47%);8/15 (73.3%) had CTX-M, SHV, TEM, 4/15 (26.67%) CTX-M, TEM, 3/15 (20.00%) CTX-M and SHV. Carbapenemase producing K. pneumoniae was found at 31.82% (7/22) phenotypically;1/7 (14.28%) by MHT, 4/7 (57.14%) Boronic acid test and 2/7 (28.58%) EDTA test. Genotypically;3/4 [(75%) 42.86%] had OXA-48, 1/4 [(25%) 14.28%] OXA-48 and KPC gene, 1/2 [(50%) 14.28%] KPC and VIM, 1/2 [(50%) 14.28%] KPC and KPC gene [(100%) 14.28%]. Conclusion/Recommendations: DDS to be used for ESBL production, MHT, Boronic Acid test and EDTA tests using Meropenem/or Imipenem for Carbapenemase-production routinely. 展开更多
关键词 Antimicrobial RESISTANCE PATTERNS ESBLs carbapenemase RESISTANCE klebsiella pneumoniae
下载PDF
新型抗KPC-2型碳青霉烯酶纳米抗体的筛选与鉴定
9
作者 张鑫 王辉 许剑锋 《中国免疫学杂志》 CAS CSCD 北大核心 2024年第6期1259-1264,共6页
目的:产KPC-2型肺炎克雷伯菌可引起β-内酰胺类抗生素、碳青霉烯类抗生素产生耐药性。通过噬菌体展示技术从抗KPC-2纳米抗体文库中筛选与KPC-2特异性结合的纳米抗体,为产KPC-2型肺炎克雷伯菌耐药性的检测和诊断提供技术支持。方法:利用... 目的:产KPC-2型肺炎克雷伯菌可引起β-内酰胺类抗生素、碳青霉烯类抗生素产生耐药性。通过噬菌体展示技术从抗KPC-2纳米抗体文库中筛选与KPC-2特异性结合的纳米抗体,为产KPC-2型肺炎克雷伯菌耐药性的检测和诊断提供技术支持。方法:利用重组KPC-2免疫双峰骆驼,从骆驼的外周血淋巴细胞中提取RNA,逆转录为cDNA,通过两轮嵌套式PCR扩增出纳米抗体片段,构建抗体文库,并通过噬菌体展示技术筛选特异性纳米抗体。通过HPLC和OCTET分别进行表位分析和亲和力测定。结果:构建了一个库容为5.47×10^(8)cfu/ml且插入有效片段不低于81.25%的纳米抗体文库;并建立抗KPC-2纳米抗体的免疫淘选方法;获得了2个不同CDR3区的纳米抗体K2和K5,亲和力分别为6.0 nmol/L和4.8 nmol/L。且在KPC-2上具有2个非竞争性结合表位。结论:成功淘选出2个不同表位的特异性纳米抗体,有望替代传统抗体用于肺炎克雷伯菌耐药性疾病的检测和诊断。 展开更多
关键词 纳米抗体 噬菌体展示技术 kpc-2型碳青霉烯酶 肺炎克雷伯菌
下载PDF
肺炎克雷伯菌产KPC酶合并膜孔蛋白OmpK36缺失对头孢他啶/阿维巴坦耐药的分子机制研究 被引量:1
10
作者 张鹏 李婕 曹若楠 《中国抗生素杂志》 CAS CSCD 北大核心 2023年第6期666-671,共6页
目的研究产KPC酶肺炎克雷伯菌(Klebsiella pneumoniae,Kp)对头孢他啶/阿维巴坦耐药的分子机制。方法临床分离2株对头孢他啶/阿维巴坦耐药的产KPC酶Kp C9和C14,利用胶体金法进行碳青霉烯酶型检测,基质辅助激光解吸飞行时间质谱(MALDI-TOF... 目的研究产KPC酶肺炎克雷伯菌(Klebsiella pneumoniae,Kp)对头孢他啶/阿维巴坦耐药的分子机制。方法临床分离2株对头孢他啶/阿维巴坦耐药的产KPC酶Kp C9和C14,利用胶体金法进行碳青霉烯酶型检测,基质辅助激光解吸飞行时间质谱(MALDI-TOF MS)进行同源性分析,MIC法进行药物最低抑菌浓度检测,聚丙烯酰胺凝胶电泳(SDS-PAGE)及基因测序检测外膜蛋白表达及基因突变,羰基氰化物间氯苯腙(CCCP)抑制试验检测主动外排机制。结果产KPC酶Kp C9和C14同其他产KPC酶Kp同源性较低,对头孢他啶/阿维巴坦的MIC分别为16和32μg/mL,外膜蛋白SDS-PAGE显示Kp C9和C14均有OmpK36的缺失,外膜蛋白基因序列分析显示Kp C9和C14的OmpK36基因序列均存在个别位点的突变、缺失,CCCP抑制试验显示CCCP不能提高Kp C9和C14对头孢他啶/阿维巴坦的敏感性。结论KPC酶合并膜孔蛋白OmpK36缺失可引起Kp对头孢他啶/阿维巴坦耐药。 展开更多
关键词 肺炎克雷伯菌 碳青霉烯酶 膜孔蛋白 头孢他啶/阿维巴坦
下载PDF
同时携带blaNDM-1和blaKPC-2基因肺炎克雷伯菌的研究 被引量:1
11
作者 王笑 王晓慧 +2 位作者 姜美妍 伦立民 朱元祺 《中国实验诊断学》 2023年第3期279-283,共5页
目的探讨某医院儿科分离的肺炎克雷伯菌对碳青霉烯类耐药的机制和菌株的同源性。方法2021年6月~2021年12月在某医院儿科住院患儿中分离出8株对碳青霉烯类耐药的肺炎克雷伯菌。细菌的鉴定和药敏采用VITEK 2系统。基于Illumina和Nanopore... 目的探讨某医院儿科分离的肺炎克雷伯菌对碳青霉烯类耐药的机制和菌株的同源性。方法2021年6月~2021年12月在某医院儿科住院患儿中分离出8株对碳青霉烯类耐药的肺炎克雷伯菌。细菌的鉴定和药敏采用VITEK 2系统。基于Illumina和Nanopore测序平台获得菌株的基因组和质粒序列,然后用软件分析菌株的生物学信息。Xba I酶切脉冲场凝胶电泳(PFGE)、S1核酸酶切脉冲场凝胶电泳(S1-PFGE)和质粒的液相接合试验分别检测菌株的同源性和携带的质粒。结果这8株肺炎克雷伯菌都携带blaNDM-1和blaKPC-2及其他的耐药基因,与呈现的多重耐药表型相符合。依据Tenover规则,这8株菌的PFGE属于相同的克隆群,且多位点序列都属于ST11型。S1-PFGE和测序结果都显示QD1株携带三个质粒,分别命名为P1(携带blaNDM-1)、P2和P3(携带blaKPC-2)。另外,液相接合显示QD1株携带的P1质粒(携带blaNDM-1)可水平传递到大肠埃希菌J53Azi^(R)。结论研究表明这些菌株对碳青霉烯类的耐药是因为携带了blaNDM-1和blaKPC-2基因。经检索,同时携带blaNDM-1和blaKPC-2基因的ST11型肺炎克雷伯菌在儿科患者中的暴发流行为国内外首次报道。 展开更多
关键词 肺炎克雷伯菌 碳青霉烯酶 blakpc-2 blaNDM-1 基因
下载PDF
产KPC酶肺炎克雷伯菌对头孢他啶/阿维巴坦耐药机制研究进展 被引量:1
12
作者 郑媚 匡徐 +2 位作者 李甫豪 冯可莹 于洋 《国外医药(抗生素分册)》 CAS 2023年第3期160-165,共6页
头孢他啶/阿维巴坦(Ceftazidime/Avibactam,CZA)是头孢他啶和一种新型β-内酰胺酶抑制剂(阿维巴坦)的组合,已被美国食品药品监督管理局和国家市场监督管理总局批准,主要用于治疗复杂的腹部和尿道感染、医院获得性细菌性肺炎和呼吸机相... 头孢他啶/阿维巴坦(Ceftazidime/Avibactam,CZA)是头孢他啶和一种新型β-内酰胺酶抑制剂(阿维巴坦)的组合,已被美国食品药品监督管理局和国家市场监督管理总局批准,主要用于治疗复杂的腹部和尿道感染、医院获得性细菌性肺炎和呼吸机相关的细菌性肺炎,特别是由肺炎克雷伯菌引起的感染和炎症。然而,CZA临床应用导致了多重耐药肺炎克雷伯菌的出现。其耐药机制主要有三种:blakpc基因的突变、细菌细胞膜孔蛋白突变和KPC酶的表达量增加。本文就耐CZA的肺炎克雷伯菌流行情况和耐药机制进行综述,旨在为临床防治CZA的耐药菌株提供科学依据,并为新药开发提供指导。 展开更多
关键词 kpc酶肺炎克雷伯菌 头孢他啶 阿维巴坦 耐药机制 作用机理 突变
下载PDF
KL47型和KL64型产KPC酶肺炎克雷伯菌的菌株特征和体外药物敏感性分析
13
作者 李晓晴 王露霞 +7 位作者 卓超 郭振辉 陈金辉 孙朝晖 廖扬 肖斌 黄晓燕 吴玉婷 《中国感染与化疗杂志》 CAS CSCD 北大核心 2023年第3期341-346,共6页
目的分析KL47型和KL64型荚膜血清型产KPC酶肺炎克雷伯菌(KPC-KP)的菌株特点,比较多黏菌素B、替加环素、头孢他啶-阿维巴坦对KL47型和KL64型KPC-KP菌株的体外抗菌活性。方法纳入2019年1月—2020年12月南部战区总医院216例患者不同部位分... 目的分析KL47型和KL64型荚膜血清型产KPC酶肺炎克雷伯菌(KPC-KP)的菌株特点,比较多黏菌素B、替加环素、头孢他啶-阿维巴坦对KL47型和KL64型KPC-KP菌株的体外抗菌活性。方法纳入2019年1月—2020年12月南部战区总医院216例患者不同部位分离的280株经PCR确认携带blaKPC的KPC-KP菌株。用wzi测序法进行荚膜血清型测定,采用肉汤微量稀释法检测多黏菌素B、替加环素、头孢他啶-阿维巴坦以及临床常用抗菌药物的最低抑菌浓度(MIC)。结果280株KPC-KP中168株为患者单一部位分离的菌株,另112株来自48例患者2~5个不同部位分离到菌株。168株荚膜血清分型以KL47型和KL64为主,分别占44.6%(75/168)和38.7%(65/168),其他荚膜血清型(KL10、KL12、KL19、KL27、KL28、KL105、KL110)占14.9%(25/168),3株(1.8%)菌株无法归类于以上血清型。112株KPC-KP中82株来自37例患者不同部位分离的菌株荚膜血清型均为同一型,另30株来自11例患者不同部位分离的菌株荚膜血清型为不同型;KL47型和KL64型分别为54.5%(61/112)和27.7%(31/112),其他荚膜血清型为12.5%(14/112),有6株(5.4%)无法归类于以上血清型。KL47型和KL64型两组患者患有基础疾病中,除慢性阻塞性肺疾病患病率差异有统计学意义(P<0.01),其余临床危险因素差异均无统计学意义(P>0.05),KL47和KL64型患者14 d及28 d死亡率差异无统计学意义(P>0.05)。136株KL47对多黏菌素B、替加环素和头孢他啶-阿维巴坦敏感率为95.6%、97.8%和98.5%,MIC_(90)分别为16、2、8 mg/L;96株KL64对多黏菌素B、替加环素和头孢他啶-阿维巴坦敏感率为88.5%、91.7%和100%,MIC_(90)分别为16、2、4 mg/L。多黏菌素B和头孢他啶-阿维巴坦对KL47和KL64体外抗菌活性相当(P>0.05),而替加环素对KL47和KL64型KPC-KP菌株体外抗菌活性差异有统计学意义(P=0.04)。结论该院KPC-KP荚膜血清型以KL47和KL64型为主。多黏菌素B和头孢他啶-阿维巴坦对KL47和KL64体外抗菌活性差异无统计学意义,替加环素对KL47具有更好的体外抗菌优势。KL64的高流行率、高耐药率可能带来临床难治愈及高死亡率,亟需感染防控措施的加强及临床流行病学监控。 展开更多
关键词 肺炎克雷伯菌 kpc 多黏菌素B 替加环素 头孢他啶-阿维巴坦
下载PDF
厦门地区医院感染大肠埃希菌及肺炎克雷伯菌产KPC的调查研究
14
作者 王夙昕 邸玥莹 +3 位作者 邹慧青 陈旭 张勇翔 张玲 《国际医药卫生导报》 2023年第11期1514-1518,共5页
目的了解厦门地区医院感染分离的大肠埃希菌及肺炎克雷伯菌产肺炎克雷伯菌碳青霉烯酶(KPC)情况及其分子流行病学特征。方法通过使用VITEK 2 COMPACT 15型全自动微生物分析系统,评估检测分离株的抗菌药物敏感性;采用改良Hodge实验以亚胺... 目的了解厦门地区医院感染分离的大肠埃希菌及肺炎克雷伯菌产肺炎克雷伯菌碳青霉烯酶(KPC)情况及其分子流行病学特征。方法通过使用VITEK 2 COMPACT 15型全自动微生物分析系统,评估检测分离株的抗菌药物敏感性;采用改良Hodge实验以亚胺培南为指示药物,对分离菌株进行碳青霉烯酶表型的筛选;采用聚合酶链反应(PCR)、测序分析阳性菌株KPC的型别;使用脉冲场凝胶电泳技术(PFGE)进行分子分型,探讨产KPC的肺炎克雷伯菌和大肠埃希菌基因型,进行聚类分析,探讨是否存在医院内播散。结果厦门地区分离的18株产KPC的大肠埃希菌和肺炎克雷伯菌对常见的抗生素呈现高度耐药,仅对多黏菌素敏感;KPC基因型为KPC-2型;PFGE结果显示,88.9%(16/18)肺炎克雷伯菌属于多个基因型,11.1%(2/18)大肠埃希菌分别属于2个基因型。结论厦门地区医院存在院际流行的KPC-2型肺炎克雷伯菌,对常见抗生素耐药,没有发生地区性的暴发流行,需要加强医院感染监测。 展开更多
关键词 大肠埃希菌 肺炎克雷伯菌 耐药性 肺炎克雷伯菌碳青霉烯酶
下载PDF
青海省碳青霉烯类耐药肠杆菌目细菌的分子流行病学分析
15
作者 何轶群 扎拉加 +3 位作者 李娟 董娟 卢天龙 黄文辉 《检验医学与临床》 CAS 2024年第22期3352-3358,共7页
目的通过研究2022年7月至2023年5月青海省5家医院分离的碳青霉烯类耐药肠杆菌目细菌(CRE)的分布、基因型及耐药性,为临床CRE感染的治疗、院内感染防控,以及抗菌药物制订和评价提供数据支持。方法采用基质辅助激光解析电离飞行时间质谱... 目的通过研究2022年7月至2023年5月青海省5家医院分离的碳青霉烯类耐药肠杆菌目细菌(CRE)的分布、基因型及耐药性,为临床CRE感染的治疗、院内感染防控,以及抗菌药物制订和评价提供数据支持。方法采用基质辅助激光解析电离飞行时间质谱仪进行细菌鉴定,采用VITEKⅡcompact进行细菌药敏试验,采用碳青霉烯酶抑制剂增强试验进行产酶表型鉴定,采用聚合酶链反应检测碳青霉烯酶基因(blaKPC、blaNDM、blaIMP、blaVIM和blaOXA-48)。对分离出的优势菌株进行多位点序列分型(MLST)和同源性分析。结果共分离出59株CRE,其中50株分离自临床标本,9株分离自患者所处的环境;59株CRE中阴沟肠杆菌23株,肺炎克雷伯菌22株,大肠埃希菌7株,产酸克雷伯菌5株,弗氏柠檬酸杆菌和布氏柠檬酸杆菌各1株。CRE主要分离于重症监护病房、烧伤科、肝胆科。标本来源主要为伤口分泌物、痰液、血液。59株CRE对酶抑制剂复合制剂、头孢菌素类、氨曲南及碳青霉烯类等抗菌药物均具有较高的耐药率(87.5%~100.0%),对阿米卡星和替加环素的耐药率相对较低,分别为30.4%和15.5%。最常见的碳青霉烯酶基因型是blaNDM(59.32%,35/59),其次是blaKPC(32.20%,19/59),肺炎克雷伯菌中blaKPC-2检出率最高(72.73%,16/22),阴沟肠杆菌中blaNDM-1检出率最高(69.57%,16/23)。MLST结果显示,肺炎克雷伯菌ST分型主要为ST11型(68.18%,15/22),阴沟肠杆菌ST分型主要为ST97型(26.09%,6/23),9株从患者所处环境中分离出的CRE与临床菌株的ST型一致。结论青海省5家医院分离的CRE耐药率普遍较高,主要以阴沟肠杆菌和肺炎克雷伯菌为主,碳青霉烯酶基因以blaNDM和blaKPC为主,耐药问题严重,临床应加强CRE的筛查及控制,预防其在院内传播。 展开更多
关键词 碳青霉烯耐药肠杆菌目细菌 耐药性 基因型 碳青霉烯酶 阴沟肠杆菌 肺炎克雷伯菌
下载PDF
Emergence of Klebsiella pneumoniae carbapenemase-producing Proteus mirabilis in Hangzhou, China 被引量:11
16
作者 SHENG Zi-ke LI Jun-jie SHENG Guo-ping SHENG Ji-fang LI Lan-juan 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第18期2568-2570,共3页
Background Carbapenems are used to treat severe infections caused by multi-drug-resistant organisms, however, the emergence of carbapenem-resistant bacterial isolates is becoming an increasing therapeutic challenge. S... Background Carbapenems are used to treat severe infections caused by multi-drug-resistant organisms, however, the emergence of carbapenem-resistant bacterial isolates is becoming an increasing therapeutic challenge. Since the first Klebsiella (K.) pneumoniae carbapenemase (KPC)-producing K. pneumoniae was reported in 2001, KPC-producing isolates have been found increasingly, specially in Enterobacteriaceae. The aim of this study was to characterize the mechanisms of a carbapenem-resistant Proteus (P.) mirabilis. Methods A carbapenem-resistant P. mirabilis isolate was recovered from pleural drainage fluid of a patient admitted to surgical intensive care unit. Antimicrobial susceptibility testing of the isolate was performed by disk diffusion according to Clinical and Laboratory Standards Institute guidelines, and subsequent minimal inhibitory concentrations were determined with the E-test. Amplification of the blaKPC gene generated a positive band and the PCR products were sequenced subsequently. The plasmid of the isolate was extracted and was successfully transformed into Escherichia (E.) coli DH5a. Results The P. mirabilis isolate was resistant to all detected antimicrobial agents except tigecycline. KPC-2 was confirmed by DNA sequence analysis. The transformant E. coil was resistant to carbapenems. Further study demonstrated that upstream and downstream regions of b/aKPC-2 were identical to that observed in K. pneumoniae submitted to GenBank from China in 2007. Conclusion Carbapenem resistance in the P. mirabilis isolate in this study is mainly due to production of KPC-2. 展开更多
关键词 ENTEROBACTERIACEAE proteus mirabilis carbapenem klebsiella pneumoniae carbapenemase
原文传递
An Outbreak of Infections Caused by a Klebsiella pneumoniae ST11 Clone Coproducing Klebsiella pneumoniae Carbapenemase-2 and RmtB in a Chinese Teaching Hospital 被引量:7
17
作者 Jun Li Ming-Xiang Zou +4 位作者 Hai-Chen Wang Qing-Ya Dou Yong-Mei Hu Qun Yan Wen-En Liu 《Chinese Medical Journal》 SCIE CAS CSCD 2016年第17期2033-2039,共7页
Background: Klebsiellapneumoniae carbapenemase (KPC)-producing K. pneumoniae bacteria, which cause serious disease outbreaks worldwide, was rarely detected in Xiangya Hospital, prior to an outbreak that occurred fr... Background: Klebsiellapneumoniae carbapenemase (KPC)-producing K. pneumoniae bacteria, which cause serious disease outbreaks worldwide, was rarely detected in Xiangya Hospital, prior to an outbreak that occurred from August 4, 2014, to March 17, 2015. The aim of this study was to analyze the epidemiology and molecular characteristics of the K. pneumoniae strains isolated during the outbreak. Methods: Nonduplicate carbapenem-resistant K. pneumoniae isolates were screened for blanc," and multiple other resistance determinants using polymerase chain reaction. Subsequent studies included pulsed-field gel electrophoresis (PFGE), multilocus sequence typing, analysis of plasmids, and genetic organization ofblaKPC-2 locus. Results: Seventeen blaKPC-2-positive K. pneumoniae were identified. A wide range of resistant determinants was detected. Most isolates (88.2%) coharbored blaKPC-2 and rmtB in addition to other resistance genes, including biaSHV-1, blaTEM-1, and aac(3)-lla. The blaKPC-2 and rmtB genes were located on the conjugative IncFIB-type plasmid. Genetic organization of blaKPC-2 locus in most strains was consistent with that of the plasmid pKP048. Four types (A l, A2, A3, and B) were detected by PFGE, and Type A1, an ST11, was the predominant PFGE type. A novel K. pneumoniae sequence type (ST1883) related to STI 1 was discovered. Conclusions: These isolates in our study appeared to be clonal and STI 1 K. pneumoniae was the predominant clone attributed to the outbreak. Coharbing of blaKPC-2 and rmtB, which were located on a transferable plasmid, in clinical K. pneumoniae isolates may lead to the emergence of a new pattern of drug resistance. 展开更多
关键词 Carbapenem: klebsiella pneumoniae klebsiella pneumoniae carbapenemase Outbreak: RmtB
原文传递
Genomic Epidemiology of Carbapenemaseproducing Klebsiella pneumoniae in China 被引量:3
18
作者 Cuidan Li Xiaoyuan Jiang +11 位作者 Tingting Yang Yingjiao Ju Zhe Yin Liya Yue Guannan Ma Xuebing Wang Ying Jing Xinhua Luo Shuangshuang Li Xue Yang Fei Chen Dongsheng Zhou 《Genomics, Proteomics & Bioinformatics》 SCIE CAS CSCD 2022年第6期1154-1167,共14页
The rapid spread of carbapenemase-producing Klebsiella pneumoniae(cpKP)poses serious threats to public health;however,the underlying genetic basis for its dissemination is still unknown.We conducted a comprehensive ge... The rapid spread of carbapenemase-producing Klebsiella pneumoniae(cpKP)poses serious threats to public health;however,the underlying genetic basis for its dissemination is still unknown.We conducted a comprehensive genomic epidemiology analysis on 420 cpKP isolates collected from 70 hospitals in 24 provinces/autonomous regions/municipalities of China during 2009–2017 by short-/long-read sequencing.The results showed that most cpKP isolates were categorized into clonal group 258(CG258),in which ST11 was the dominant clone.Phylogenetic analysis revealed three major clades including the top one of Clade 3 for CG258 cpKP isolates.Additionally,carbapenemase gene analysis indicated that blaKPC was dominant in the cpKP isolates,and most blaKPC genes were located in five major incompatibility(Inc)groups of blaKPC-harboring plasmids.Importantly,three advantageous combinations of host–blaKPC-carrying plasmid(Clade 3.1+3.2–IncFIIpHN7A8,Clade 3.1+3.2–IncFIIpHN7A8:IncR,and Clade 3.3–IncFIIpHN7A8:IncpA1763-KPC)were identified to confer cpKP isolates the advantages in both genotypes(strong correlation/coevolution)and phenotypes(resistance/growth/competition)to facilitate the nationwide spread of ST11/CG258 cpKP.Intriguingly,Bayesian skyline analysis illustrated that the three advantageous combinations might be directly associated with the strong population expansion during 2007–2008 and subsequent maintenance of the population of ST11/CG258 cpKP after 2008.We then examined drug resistance profiles of these cpKP isolates and proposed combination treatment regimens for CG258/non-CG258 cpKP infections.Thus,the findings of our systematical analysis shed light on the molecular epidemiology and genetic basis for the dissemination of ST11/CG258 cpKP in China,and much emphasis should be given to the close monitoring of advantageous cpKP–plasmid combinations. 展开更多
关键词 klebsiella pneumoniae Drug resistance carbapenemase PLASMID Genomic epidemiology
原文传递
Emergence of Klebsiella pneumoniae carbapenemase-producing Escherichia coli sequence type 131 in Hangzhou, China 被引量:1
19
作者 Lou Zhengqing Qi Yan +2 位作者 Qian Xiang Yang Wei Wei Zeqing 《Chinese Medical Journal》 SCIE CAS CSCD 2014年第3期528-531,共4页
Background Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia (E.) coil has been reported in China since 2008.However,there is no information about the molecular epidemiology of KPC-producing E.coil i... Background Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia (E.) coil has been reported in China since 2008.However,there is no information about the molecular epidemiology of KPC-producing E.coil in China.In this study,we aimed to investigate the sequence type (ST) and characteristics of KPC-producing E.coil isolates in China.Methods Three carbapenem-resistant isolates of E.coil (E1,E2,and E3) from one teaching hospital in Hangzhou covering a one year period were analyzed.Antibiotic susceptibility was determined by Etest.Pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) were used for epidemiological analysis.The genetic structure around blaKPC,the major plasmid incompatibility typing,and the identification of 3-lactamase gene types were performed by PCR and the positive products were subsequently sequenced.Plasmids were analyzed by transformation,restriction,and Southern blotting.Results PFGE demonstrated that patterns of isolates E1 and E2 were clonally-related and designated as patterns A1 and A2; pattern of isolate E3 was different and designated as pattern B.MLST analysis showed that the three isolates displayed one common sequence type ST131.The identification of bla gene types by PCR and sequencing showed that blaKPC-2,blaCTX-M-14,and blaTEM-1 were detected in all three isolates.All three isolates carried a KPC-2-encoding plasmid of the IncN replicon.Plasmid analysis and hybridization experiments showed that the isolates were found simultaneously to carry two or four plasmids.The blaKPc-2 gene in E1 and E2 was located in a plasmid with size of ca.50 kb.However,the blaKPC-2 gene in E3 was located in a plasmid with size of ca.130 kb.Conclusions E.coil ST131 with KPC-2 β-1actamase has emerged in China,which enlarges the geographical area where the ST131 KPC-oroducing E.coil strains have diffused. 展开更多
关键词 klebsiella pneumoniae carbapenemase Escherichia coli sequence type
原文传递
T6SS阳性CRKP临床感染特征及毒力基因分析
20
作者 刘莉娟 储雯雯 +4 位作者 王梦 闫涛 龚真 周强 刘周 《中国感染控制杂志》 CAS CSCD 北大核心 2024年第4期488-493,共6页
目的分析T6SS阳性耐碳青霉烯类肺炎克雷伯菌(CRKP)临床感染特征,以及其耐药、毒力基因检出率和生物膜形成能力,为临床防控CRKP感染提供参考数据。方法收集2019年1月—2022年12月安徽某三甲医院临床分离的CRKP菌株及患者资料,PCR法检测T... 目的分析T6SS阳性耐碳青霉烯类肺炎克雷伯菌(CRKP)临床感染特征,以及其耐药、毒力基因检出率和生物膜形成能力,为临床防控CRKP感染提供参考数据。方法收集2019年1月—2022年12月安徽某三甲医院临床分离的CRKP菌株及患者资料,PCR法检测T6SS基因、毒力基因、耐药基因和分子分型,96孔板结晶紫染色法检测生物膜形成能力。结果共纳入160株CRKP。标本来源以痰(46.9%)和血(26.3%)为主。CRKP菌株呈现多重耐药表型,以携带bla KPC(80.6%)为主,其次为bla NDM(17.5%)。根据是否携带T6SS将CRKP分为T6SS阳性组(129株,80.6%)和T6SS阴性组(31株,19.4%)。T6SS阳性组患者患慢性肺部疾病和心脏疾病比例高于T6SS阴性组(P<0.05),且预后较阴性组差(P<0.05)。T6SS阳性组中,iuc A、mrk D、rmp A2、peg 344、wab G、fim H检出率均高于T6SS阴性组(均P<0.05)。CRKP中以ST11型(68.8%)为主,其中K64-ST11型占比70.9%,K47-ST11型占比25.5%。T6SS阳性组ST11型和K64-ST11型CRKP占比均高于T6SS阴性组(均P<0.05)。T6SS阳性组CRKP生物膜形成能力强于T6SS阴性组(P<0.001)。两组除bla OXA-48基因外,在携带其他碳青霉烯类耐药基因和抗菌药物耐药率方面差异无统计学意义。结论该地区CRKP呈现多重耐药,CRKP菌株T6SS检出率高,T6SS阳性CRKP毒力基因检出率更高,且生物膜形成能力更强。 展开更多
关键词 肺炎克雷伯菌 T6SS 毒力基因 耐碳青霉烯类 碳青霉烯酶
下载PDF
上一页 1 2 15 下一页 到第
使用帮助 返回顶部